WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):
-Earnings: -$129.71 million in Q3 vs. -$108.59 million in the same period last year. -EPS: -$0.70 in Q3 vs. -$0.61 in the same period last year. -Analysts projected -$0.80 per share -Revenue: $24.92 million in Q3 vs. $30.03 million in the same period last year.
Copyright RTT News/dpa-AFX